MYH9 and colonic neoplasm: Notably, validation using an independent cohort of colon cancer patients established that co-expression of MYH9 and other genes correlated with poorer clinical outcomes in terms of overall and disease-free survival (p < 0.001) (Lee C. J. et al., 2023).